Regulatory news 26 aprile 2024 Teva enters into oncology biosimilar licensing agreement with mAbxience
Normativa europea Regulatory news 24 aprile 2024 New recommendations to strengthen supply chains of critical medicines
Prodotti competitors / Area Oncology 24 aprile 2024 BeiGene receives European Commission Approval for Tislelizumab as treatment for Non-Small Cell Lung Cancer (NSCLC)
Prodotti competitors / Area Liver 8 aprile 2024 Europe - PRIME Designation for BJT-778 in chronic HDV
Prodotti competitors / Area COVID-19 26 marzo 2024 Invivyd's PEMGARDA (pemivibart) receives from FDA the Emergency Use Authorization (EUA) for the pre-exposure prophylaxis (PrEP) of COVID-19 in adults and adolescents with moderate-to-severe immune compromise
Prodotti competitors / Area Kite 23 marzo 2024 US- FDA Oncologic Drugs Advisory Committee (ODAC) Supported Janssen’s Carvykti and BMS’ Abecma Indication Expansion for Multiple Myeloma on Mar. 15, 2024
Prodotti competitors / Area Oncology 23 marzo 2024 Europe - Oncology CHMP Meeting Highlights 18-21 March 2024
Prodotti competitors / Area Liver 22 marzo 2024 Emblaveo (aztreonam-avibactam): new antibiotic to fight infections caused by multidrug-resistant bacteria reccomended by the CHMP for approval
